About conference On behalf of the 31st European Heart & Heart Failure Congress Committee we invite all the eminent speakers round the world to join the international live online webinars scheduled on June 18-19, 2020. EURO HEART FAILURE 2020 The incorporation of new technologies and research findings will be a special focus of the Congress. It will also bring together expert clinicians, researchers and leaders of cardiac health stakeholder organisations, offering an outstanding set of plenary and state-of - the-art lectures, educational courses, Online symposia with experts and sessions designed by cardiology professionals and cardiac specialists and for early careers. The main aim of EURO HEART FAILURE 2020 is to provide an excellent platform for the exchange of ideas and authoritative opinions by leading scientists covering the entire spectrum of cardiovascular disease and heart failure research and sharing the cross-cultural experiences of different treatment procedures. EURO HEART FAILURE 2020 is an international conference of cardiologists and heart failure committee to discuss the future of cardiac health and cardiovascular disorders in terms of collaboration, structures and organizational development and advances in cardio-metabolic health and Interventional Cardiology. The EURO HEART FAILURE 2020 will be organized around the theme "Mission to fight against Heart Diseases and Heart Failure". Why to attend??? With members from around the world concentrated on learning about cardiothoracic and its advances; this is your best opportunity to reach the biggest summit of participants from the cardiology & coronary disease community. Lead presentations, distribute information, meet with current and potential scientists, mark a splash with new drug developments, and receive name recognition at this 2-day conference. Well known renowned speakers, the most recent techniques, developments, and the newest updates in Cardiothoracic are signs of this Event. The participants can find exclusive sessions and panel discussions on latest revolutions in Cardiac Surgeries and Heart Failure by: Lectures from renowned speakers

Keynote forums by Prominent Professors

Open Invention Challenges

Live video presentations by Young Researchers

Unique techniques to improve your research

Perfect platform for World-wide business and Networking opportunities

Come across with the editors of referred journals, Society and Association members across the world Target Audience: Cardiology Scientists Cardiac Physicians Cardiac Nurses Heart Disease Researchers Cardiology Fellows Neuro-Cardiology Experts Medical Colleges Cardiology Associations and Societies Manufacturing Medical Devices Companies Business Entrepreneurs Training Institutes

Market analysis Coronary artery disease is the common form of heart disease and the most common cause of heart failure. The disease results from the build-up of plaque in your arteries, which reduce blood flow and can lead to heart attack. Heart failure affects people of all ages, from children and young adults to the middle-aged and the senior citizens. Almost 1.4 million persons with CHD are under 60 years of age. CHD is present in 2 percent of persons age 40 to 59. More than 5 percent of persons age 60 to 69 have CHD. According to the latest WHO data published in 2017 Coronary Heart Disease Demises in France reached 33,637 or 35.02% of total deaths. Survival rates in patients with heart failure were 75.9% (95% confidence interval 75.5% to 76.3%) at one year, 45.5% (45.1 to 46.0) at five years, 24.5% (23.9 to 25.0) at 10 years, and 12.7% (11.9 to 13.5) at 15 years. Since 2006 to 2016, the yearly mortality rate creditable to coronary heart disease declined 31.8% and the actual number of deaths declined 14.6%, but the problem and risk factors remain terrifyingly high. The estimated direct and indirect cost of heart disease in 2015 to 2016 (average annual) was $218.7 billion. Growth of Cardiology Market:- Overall, one, five, and 10 year survival rates increased by 6.6% (from 74.2% in 2000 to 80.8% in 2016), 7.2% (from 41.0% in 2000 to 48.2% in 2012), and 6.4% (from 19.8% in 2000 to 26.2% in 2007), respectively. There were 30 906 demises in the heart failure group over the study period. Heart failure was listed on the death record in 13 093 (42.4%) of these patients, and in 2237 (7.2%) it was the primary cause of death. Improvement in survival was greater for patients not requiring admission to hospital around the time of diagnosis (median difference 2.4 years; 5.3 v 2.9 years, P<0.001). There was a deprivation gap in median survival of 0.5 years between people who were least deprived and those who were most deprived (4.6 v 4.1 years, P<0.001). The goal of this is to evaluate cardiovascular risk among the France population quantify the impact of main risk factors on cardiovascular mortality and to identify potential modifiable factors for improving the cardiovascular health. Treatment: The FDA approved the combination tablet sacubitril/valsartan (Entresto) in 2015 to reduce the risk of cardiovascular death and hospitalization for heart failure in patients with NYHA class II-IV heart failure and reduced ejection fraction. Coronary bypass surgery

Heart valve repair or replacement

valve repair or replacement Implantable cardioverter-defibrillators (ICDs)

Cardiac resynchronization therapy (CRT)

resynchronization therapy (CRT) Ventricular assist devices (VADs)

Heart transplant. So cardiology conferences are going to be a good success today because the awareness for the treatment of vas diseases is enormously essential among the individuals and everyone can come back to grasp about the new researches happening and innovations within the field of medicine

Visa Assistance Euro Heart Failure 2020 will be happy to help you in all ways to plan your trip to Paris, France. We will be happy to help you with the official invitation letter for the approval of your VISA. Mail us at: [email protected] For that you have to confirm your participation at the conference and the mode of participation and provide with the following information: Full Name (as per your passport) Postal address Mode of participation Payment details If you have a keynote, invited, oral or poster presentation, please provide the details of your registration. The overseas visitors outside Europe entering France should hold a valid passport with at least 6 months validity from date of entry. Citizen having passport from certain countries needs a VISA to enter in the France. For more information about visa for business trips and to attend conferences in Paris, please contact the France Embassy or Consulate in your country. It should be noted that the invitation letter will be send to the participant by E-mail only. Please be aware that we would not able to directly contact to consulates or embassies regarding any visa issue. As the participant, it is your sole responsibility to apply and follow up your Visa application.

Virtual/Video Presentation Get Global Networking from your Door Step! Video is a King- Use the power of the narrative with video to make your presentations more compelling Why Virtual/Video Presentation? A video created professionally will keep the viewer’s more concentrated and engaging with the overall content; it will tell your story and emotional responses. As a speaker, video presentation aligns perfectly with your goals: you want an informed audience to think about and act on the knowledge you convey. Using video, which uses sight and sound to reel the viewer in, enhancing the audience's experience, is simple. A short video will give them better insights into your dream or strategy and, more importantly, it will help everyone. You're going to communicate more with less. Virtual / video presentations are enormously interested in creating actual presentations to learners, and video is shown to be an expanding presentation channel. Currently, our 2000 + speakers (with VISA issues, scheduling conflicts, etc.) are using video presentations worldwide. Video Presentation Opportunity: Due to various issues such as time constraints and visas, unavailability to travel to the country. A video presentation is one of the best options on a global platform to spread your research. During the conference proceedings, having played video will definitely help your research with the intent of online visibility. • No Travel Plan & Agreements • No Visa Issues • No Appointment to be cancelled • No Break from the regular schedule Benefits of opting Video Presentation: • Speaker video presentation will be officially recognized • One of the scientific committees will represent the presentation on behalf of the speaker • Session Chair suggestions and comments will be communicated after the conference • Publication of Abstract in the Souvenir and International Journal with unique DOI • Certification by the International Organizing Committee (IOCM) • Conference Souvenir (Hardcopy) delivery to presenter address Details for Video Presenter: • Record your presentation video and send us through www.wetransfer.com • Duration of the video: 20 -25 minutes • Registration Fee: $200 Simply record your presentation with high clarity via Camera / Phone and send it to the same to the Program Manager which will be displayed on Speaker Name at the conference venue and will also be available on the website along with other conference presentations. In this regard, we take the great pleasure to invite you all to be the speaker at “31st European Heart Diseases & Heart Failure Congress” scheduled during June 18-19, 2020 at Paris, France” under the Video Presentation category.